Danaher Corp

NYSE:DHRUnited States

Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three business segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a range of instruments, consumables, services and software that are primarily used by customers to study genomics and the basic building blocks of life, including deoxyribonucleic acid (DNA)and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.

Contact Information

Headquarters

2200 Pennsylvania Ave NW Ste 800WWASHINGTON, DC, United States 20037-1731

Phone

202-828-0850

Fax

202-828-0860

Executives

Chairman of the Board

Steven Rales

President, Chief Executive Officer, Director

Rainer Blair

Co-Founder, Director

Mitchell Rales

Chief Financial Officer, Executive Vice President

Matthew McGrew

Executive Vice President - Biotechnology

Christopher Riley